AARP Hearing Center
After decades of warnings that antipsychotic medications carry risks for people with dementia, a new study suggests that about 1 in 4 Medicare beneficiaries with dementia are still prescribed brain-altering drugs, such as antipsychotics, benzodiazepines and barbiturates. And a 2024 study suggests that these drugs — developed to treat conditions like bipolar disorder and schizophrenia — pose more risks to people with dementia than previously known.
In people with dementia who are age 50 and older, taking antipsychotics more than doubled the risk of pneumonia, the most common cause of death in people with dementia. And along with the known threat of stroke, the drugs increased the risk of acute kidney injury, blood clots, bone fracture, heart attack and heart failure.
Risks were greatest in the first week after patients started antipsychotic medications, according to the study, reported by U.K. researchers in BMJ. The team analyzed health records of nearly 174,000 people in the United Kingdom diagnosed with dementia from January 1998 to May 2018. About two-thirds were women, and their average age at diagnosis was 82.
The drugs risperidone, haloperidol, quetiapine and olanzapine accounted for nearly 80 percent of the antipsychotic prescriptions in the study.
About 4.5 percent of people with dementia developed pneumonia during the first 90 days of antipsychotic use, and 10 percent developed pneumonia within the first year. Those rates were two to three times higher than in similar patients not prescribed antipsychotics.
More From AARP
How to Manage 8 Dementia-Related Behaviors
Finding the right solution requires steady sleuthing, calm compassion
The Unique Challenges of Dementia Caregiving
Tips on how to manage such often-difficult care
Brain Health Resource Center
Find explainers on diseases of the brain plus healthy habits to support memory and mental skillsRecommended for You